Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00224952 · ClinicalTrials.gov registry record
Pathogenesis of Adverse Drug Reactions
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 274
- Enrollment target
NCT00224952 is a clinical trial that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 274 participants.
The verdict
NCT00224952 has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 274 participants
- Enrollment target
Study Summary
The purpose of the study is to examine the individual metabolic profiles of pediatric patients receiving carbamazepine or valproate therapy, in an attempt to determine identities of the reactive metabolites or, alternatively, the identities of those metabolites that serve as potential precursors to reactive species.
Interventions
- OTHER No intervention; Urine Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 274 participants |
| Start Date | 2002-07 |
| Est. Completion | 2010-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00224952
The ClinicalTrials.gov registry entry for NCT00224952 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 274 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention; Urine Collection is the first listed.
NCT00224952 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00224952 about?
NCT00224952 is a clinical study titled "Pathogenesis of Adverse Drug Reactions". The purpose of the study is to examine the individual metabolic profiles of pediatric patients receiving carbamazepine or valproate therapy, in an attempt to determine identities of the reactive metabolites or, alternatively, the identities of those metabolites that serve as potential precursors to ...
What is the current status of trial NCT00224952?
This trial is currently completed. The enrollment target is 274 participants. The study started on 2002-07. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00224952?
The interventions under investigation include: No intervention; Urine Collection (OTHER).
Who is sponsoring clinical trial NCT00224952?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.